A

Ascertain

Launches AI-powered healthcare companies platform

Director – Strategic Sales - Cardiology

Full-Time
$130k - $150k/yr+ Equity + Uncapped sales upside
Expert
Bachelor's
Remote in USA
Remote
Sales & Account ManagementAccount Executive

About the job

Requirements
  • 8–12+ years of B2B enterprise healthcare sales experience, ideally selling software, digital health, medical devices, revenue cycle solutions, or other complex solutions into healthcare organizations.
  • Demonstrated success building pipeline and winning new business in the cardiovascular market, rather than primarily managing or expanding an existing book of accounts.
  • Strong consultative enterprise selling skills and commercial judgment, including the ability to understand a customer’s business model, build a compelling economic case for change, and navigate complex sales cycles.
  • An entrepreneurial, relationship-driven approach to sales, with the ability to earn credibility with senior healthcare leaders and effectively orchestrate technical, operational, implementation, and subject matter experts throughout the sales process.
  • Bachelor’s degree and a track record of performing against ambitious commercial goals, with motivation to succeed in a performance-driven environment where exceptional results are meaningfully rewarded.
Responsibilities
  • Own the full enterprise sales cycle for Ascertain’s cardiology business, from prospecting and pipeline development through negotiation and close, working with MSOs, regional groups, and affiliated hospital cardiology practices to deliver against a multimillion-dollar revenue target.
  • Lead sophisticated, consultative sales conversations with executives, operators, clinicians, and financial stakeholders, building consensus across complex buying groups.
  • Orchestrate the right Ascertain resources to advance opportunities, bringing in Partner Solutions, Implementation, Product, and clinical or operational subject matter experts at the right points in the sales process.
  • Maintain strong commercial and forecasting discipline, keeping CRM and pipeline data current and partnering with Product, Finance, and other internal teams to provide reliable visibility into the business.
  • Help build Ascertain’s cardiology commercial function, using customer insights, market feedback, and competitive intelligence to shape go-to-market strategy and developing additional commercial teammates as the business grows.
Desired Qualifications
  • Experience with Challenger, MEDDICC, or similar sales methodologies.
  • Experience selling into vascular, ambulatory surgery, or ambulatory imaging organizations.
  • Experience with healthcare revenue cycle management, prior authorization, practice management, or other administrative workflows.
  • Experience at a healthcare technology, medical device/imaging, or enterprise technology organization known for rigorous sales training, with existing relationships with leaders across cardiology practices, cardiology groups, or adjacent ambulatory healthcare organizations.
  • Experience helping establish a new market, service line, or commercial motion rather than inheriting a mature territory.

About the company

Ascertain combines healthcare and technology to create AI-powered healthcare ventures. It partners with health systems, most notably Northwell Health, and Aegis Ventures to build and launch AI-enabled companies at scale. The company uses its platform and interdisciplinary team of clinicians, engineers, and business leaders to identify operational opportunities, assemble capable operators, and bring AI tools to healthcare settings. Its products focus on reducing administrative work for clinicians and improving patient care, enabling health systems to serve their communities more effectively. Revenue comes from creating and launching AI-driven healthcare companies that operate on Ascertain’s platform, with the aim of transforming medicine and expanding equitable access to care.

Company Size

51-200

Company Stage

Series A

Total Funding

$110M

Headquarters

New York City, New York

Founded

2022

Get referred to Ascertain

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Ascertain raised $10 million Series A from Deerfield Management and Northwell Health in April 2025.
  • The Oncology Institute cut authorization submission time over 80 percent and saved staff hours.
  • Ascertain won 2026 New York Digital Health 100 recognition, strengthening hiring and sales momentum.

What critics are saying

  • Prior authorization AI faces entrenched rivals like Waystar, Cohere Health, and Infinitus.
  • Ascertain still depends on Northwell and Deerfield for distribution and credibility.
  • If payer portals block automation, Ascertain's economics collapse before 2026 scaling gains.

What makes Ascertain unique

  • Northwell Health and Aegis Ventures built Ascertain as a company-creation platform in 2022.
  • Its agentic AI handles end-to-end prior authorization, not isolated workflow fragments.
  • The Oncology Institute deployment hit live production in eight weeks across 100-plus clinics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Flexible Work Hours
  • Company Equity

Growth & Insights and Company News

Headcount

6 month growth

8%

1 year growth

3%

2 year growth

-1%
Business Insider
May 2nd, 2025
Ascertain secures $10M for AI in healthcare

Ascertain, led by ex-Amazon exec Dr. Mark Michalski, raised $10 million in Series A funding to alleviate healthcare administrative burdens using AI. The round was led by Deerfield Management, with participation from Northwell Health. Ascertain's AI platform aids hospitals with tasks like clinical documentation and compliance management. The startup, launched in 2022, collaborates closely with Northwell Health and plans to expand through Deerfield's healthcare portfolio.

TechNews180
Apr 23rd, 2025
Ascertain Raises $10M to Expand Healthcare AI Tools

Healthcare AI company Ascertain has raised $10 million in a Series A funding round led by Deerfield Management, with strategic backing from Northwell Health.

FinSMEs
Apr 22nd, 2025
Ascertain Raises $10M in Series A Funding

Ascertain, a NYC-based healthcare technology company empowering care teams with AI, raised $10m in Series A funding.

Indica News
Apr 22nd, 2025
Ascertain Secures $10M for AI Platform

Ascertain, a healthcare technology company, has raised $10 million in Series A funding led by Deerfield Management, with participation from Northwell Health. The funding will help scale Ascertain's AI platform, which automates administrative tasks in healthcare, improving efficiency and patient care. Ascertain's solutions address labor shortages and streamline workflows, allowing healthcare professionals to focus more on patient care. The company will move into Deerfield's NYC headquarters.

PR Newswire
Aug 22nd, 2023
Ascertain Announces Leadership Team With Appointment Of Ceo Mark Michalski, M.D. And Executive Chairman Gregg Fergus

Michalski, an Amazon alum, and Fergus, ex-CEO of 4Catalyzer, will lead the company creation platform building AI applications in healthcare.NEW YORK, Aug. 22, 2023 /PRNewswire/ -- Ascertain, a healthcare AI company creation platform, today announced the formation of its leadership team with the appointment of CEO Mark Michalski, M.D. and Executive Chairman, Gregg Fergus. Michalski and Fergus will lead Ascertain in its mission to merge deep technical, operational, and clinical expertise to deliver high-quality, equitable, and affordable healthcare.Michalski brings two decades of executive leadership experience to Ascertain. Prior to Ascertain, Michalski led strategic development for healthcare and life sciences at Amazon, was Founding Executive Director at Mass General Brigham/Harvard's Center for Clinical Data Science, and served as President and CMO of two publicly traded companies - Butterfly Network and Hyperfine Research. He is a board-certified radiologist and completed his medical training at Yale and Stanford.Fergus and Michalski met and collaborated closely at the venture studio 4Catalyzer where Fergus was CEO, launching several leading healthcare companies including Butterfly Network, Hyperfine Research, AI Therapeutics, and Quantum Si